47,003 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Purchased by Global Assets Advisory LLC

Global Assets Advisory LLC bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 47,003 shares of the company’s stock, valued at approximately $4,273,000.

Other institutional investors have also recently made changes to their positions in the company. Envestnet Portfolio Solutions Inc. purchased a new position in shares of GE HealthCare Technologies in the third quarter valued at about $256,000. LPL Financial LLC raised its stake in shares of GE HealthCare Technologies by 22.2% in the third quarter. LPL Financial LLC now owns 173,597 shares of the company’s stock worth $11,812,000 after purchasing an additional 31,565 shares during the last quarter. Federated Hermes Inc. lifted its stake in GE HealthCare Technologies by 90.4% during the 3rd quarter. Federated Hermes Inc. now owns 77,689 shares of the company’s stock valued at $5,286,000 after acquiring an additional 36,886 shares during the period. Cary Street Partners Investment Advisory LLC grew its position in GE HealthCare Technologies by 96.3% in the 3rd quarter. Cary Street Partners Investment Advisory LLC now owns 1,629 shares of the company’s stock worth $111,000 after purchasing an additional 799 shares during the period. Finally, Meiji Yasuda Asset Management Co Ltd. increased its position in GE HealthCare Technologies by 30.7% during the third quarter. Meiji Yasuda Asset Management Co Ltd. now owns 4,475 shares of the company’s stock valued at $304,000 after acquiring an additional 1,050 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.4 %

GEHC opened at $78.85 on Tuesday. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50. The firm has a market capitalization of $35.99 billion, a P/E ratio of 23.06, a P/E/G ratio of 2.85 and a beta of 1.22. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.11. The firm’s 50 day moving average is $80.39 and its 200-day moving average is $81.66.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, meeting the consensus estimate of $0.90. The company had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The business’s revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.85 earnings per share. Analysts expect that GE HealthCare Technologies Inc. will post 4.27 EPS for the current fiscal year.

Analysts Set New Price Targets

GEHC has been the subject of several recent analyst reports. Citigroup upped their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Bank of America decreased their price objective on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 1st. Evercore ISI lifted their price target on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Argus increased their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, April 1st. Finally, Mizuho decreased their price target on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research note on Wednesday, May 1st. Five equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $94.09.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CTO Taha Kass-Hout sold 3,300 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total value of $259,710.00. Following the completion of the transaction, the chief technology officer now directly owns 67,300 shares in the company, valued at $5,296,510. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other GE HealthCare Technologies news, insider Frank R. Jimenez bought 1,315 shares of the firm’s stock in a transaction that occurred on Wednesday, May 1st. The stock was purchased at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the purchase, the insider now directly owns 75,796 shares in the company, valued at $5,799,909.92. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CTO Taha Kass-Hout sold 3,300 shares of the business’s stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total value of $259,710.00. Following the sale, the chief technology officer now owns 67,300 shares in the company, valued at $5,296,510. The disclosure for this sale can be found here. Insiders sold a total of 90,482 shares of company stock valued at $7,369,137 over the last ninety days. Insiders own 0.27% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.